Toxoplasma P32

Toxoplasma Gondii P32 (GRA6) Recombinant
Cat. No.
BT8180
Source
Escherichia Coli.
Synonyms
Appearance
Sterile Filtered solution.
Purity
Toxoplasma protein is >95% pure as determined by 10% PAGE (coomassie staining).
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

Recombinant Toxoplasma Gondii P32 (GRA6) produced in E.coli containing 180 amino acids of the Dense Granule Antigen 6 (GRA6) and fused with a 6xHis tag at C- terminus. This antigen forms dimers on SDS-PAGE under denatured conditions, compared to other toxoplasma monomer antigens, it has better immunoreactions.

Product Specs

Introduction
Toxoplasma gondii, a parasitic protozoan, exhibits a two-phase life cycle. The sexual phase is exclusively found in felids (cats), the definitive hosts. Conversely, the asexual phase can occur in a wide range of warm-blooded animals, including mammals and birds, serving as intermediate hosts. Following invasion of host cells, T. gondii establishes intracellular compartments known as parasitophorous vacuoles, containing slowly multiplying bradyzoites. These vacuoles predominantly form tissue cysts in muscle and brain tissue, evading the host's immune system due to their intracellular location. While antibiotic susceptibility varies, complete eradication of these cysts remains challenging. Within these vacuoles, T. gondii replicates through binary fission until the host cell ruptures, releasing motile, rapidly replicating tachyzoites. Unlike bradyzoites, tachyzoites are typically eliminated by the host's immune response, although some may infect new cells and transform into bradyzoites, perpetuating the infection.
Description
This product consists of a recombinant Toxoplasma gondii P32 (GRA6) protein expressed in E. coli. The protein comprises 180 amino acids of the Dense Granule Antigen 6 (GRA6) fused with a 6xHis tag at the C-terminus. Unlike other Toxoplasma antigens that are typically monomeric, this antigen forms dimers under denaturing conditions on SDS-PAGE, enhancing its immunoreactivity.
Physical Appearance
The product is provided as a clear, sterile-filtered solution.
Formulation
The product is provided in a sterile-filtered solution containing phosphate-buffered saline (PBS) and 25mM arginine.
Stability

For optimal stability, Toxoplasma P32 should be stored at -18°C. While the protein remains stable at 4°C for up to one week, repeated freeze-thaw cycles should be avoided.

Purity
The purity of the Toxoplasma protein is greater than 95% as determined by SDS-PAGE analysis and Coomassie blue staining.
Applications
This product is recommended for use in immunoassays.
Source
Escherichia Coli.
Purification Method
Toxoplasma protein was purified by proprietary chromatographic technique.

Product Science Overview

Introduction

Toxoplasma gondii is an obligate intracellular protozoan parasite that causes toxoplasmosis, a disease with significant clinical implications, particularly in immunocompromised individuals and pregnant women. The parasite has a complex life cycle involving both definitive and intermediate hosts, and it can infect a wide range of warm-blooded animals, including humans .

Toxoplasma Gondii P32 (GRA6)

The P32 antigen, also known as Dense Granule Antigen 6 (GRA6), is one of the many proteins secreted by Toxoplasma gondii. These dense granule proteins are released into the parasitophorous vacuole, a specialized compartment formed by the parasite within the host cell, and play crucial roles in modulating the host’s immune response and facilitating the parasite’s survival and replication .

Recombinant GRA6

Recombinant Toxoplasma gondii P32 (GRA6) is produced in Escherichia coli and contains 180 amino acids of the GRA6 protein. It is fused with a 6xHis tag at the C-terminus, which aids in its purification and detection. This recombinant protein forms dimers on SDS-PAGE under denatured conditions, and compared to other Toxoplasma monomer antigens, it exhibits better immunoreactivity .

Immunogenicity and Applications

GRA6 has shown strong immunogenicity in both mouse and human antibody profiles. It is recognized by the immune system of individuals infected with Toxoplasma gondii, making it a valuable antigen for the development of diagnostic assays and potential vaccines . The immunogenic properties of GRA6 have been leveraged in various studies to improve the sensitivity and specificity of serological tests for toxoplasmosis .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.